Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 5;184:106424. doi: 10.1016/j.phrs.2022.106424

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Elsevier Ltd. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 10 — Effect of NRICM102 on TGF-β-induced EMT and FMT. (A) Representative immunofluorescence images of EMT of human bronchial epithelial cells (BEAS-2B cells). Green indicates the expression of fibronectin (FN1), and blue indicates DAPI staining. Ratio of the average FN1 fluorescence intensity per cell obtained after stimulation with TGF-β or TGF-β + NRICM102 at different concentrations. (B) Representative immunofluorescence images of FMT of human fibroblast cells (HFL-1 cells). Green indicates the expression of α-SMA, and blue indicates DAPI staining. Ratio of the average α-SMA fluorescence intensity per cell obtained after stimulation with TGF-β or TGF-β + NRICM102 at different concentrations. (** p < 0.01 by one-way ANOVA followed by the S-N-K t-test).